In May 2024 a wave of headlines announced that ultraviolet light increases appetite but prevents weight gain, and that the finding could open "new approaches to treat obesity."2 The paper behind them appeared in the Journal of Investigative Dermatology from a dermatology lab at Seoul National University.1 It is a mouse study. The mice were female, their backs were shaved, and they were put under UVB lamps three times a week for twelve weeks at a dose set to redden the skin after every session. Here is what the study did, what it found, and what it can and cannot tell a person who spends time in the sun.
Key takeaways
- Female mice given 1 to 4 minimal erythema doses of UVB three times weekly for 12 weeks ate more food than sham-treated mice but gained less weight, with the clearest difference in mice on a 60% fat diet.1
- Norepinephrine rose in the blood by week 2. Leptin did not fall until week 8, and food intake did not climb until about week 7.1
- Subcutaneous fat turned beige and made more UCP1. The mice used more oxygen and produced more heat without moving more.1
- Blocking norepinephrine synthesis with the drug nepicastat reversed the weight protection.1
- The study measured food intake per cage, with 2 to 4 cages per group. The authors call norepinephrine a "fight-or-flight stress hormone," and the same lab reported in 2017 that UV on mouse skin activates the stress axis.1,3
- The only human data is a dish of cultured fat cells. The authors advise minimizing UV and plan to develop products that mimic it.1,2
- The sun-safety advice attached to the study is one side of an open debate. A 20-year Swedish cohort linked sun avoidance to shorter life, and several studies find melanoma deaths lower in people with more sun damage, not more.8,9,10
This article is for education only. It does not diagnose, treat, or prevent any condition. I am a clinical herbalist, not a physician. Do not start, stop, or change any medication or sun practice based on what you read here. UV exposure interacts with many medications and medical conditions, and responses vary between individuals. If you are pregnant, have liver disease, or are scheduled for surgery, speak with your care provider before changing anything about your routine. If you are in crisis, contact your local emergency number or crisis line.
Where the headline came from
Evidence: publisher press release and the paper it describes.
Elsevier, which publishes the journal, issued a press release on May 22, 2024, the day the paper went online.2 ScienceDaily, Neuroscience News, SciTechDaily and others ran versions of it. The release says UV exposure raised norepinephrine, lowered leptin, and browned subcutaneous fat, and that the results "potentially pave the way for new approaches to prevent and treat obesity."2 It does not mention the sex of the mice, the dose, the schedule, or the group sizes. Those details are in the paper, and they change how the result reads.
What the researchers did
Evidence: animal study, one laboratory, two parallel runs plus one inhibitor run.
The team bought female C57BL/6 mice at five weeks old and split them into four groups: a normal diet with 10% of calories from fat, or a high-fat diet with 60% of calories from fat, each with either UV or sham treatment.1 The dorsal skin was shaved and kept hairless with weekly hair removal. The UV source was a bank of fluorescent sunlamps emitting 275 to 380 nm with a peak at 310 to 315 nm, which is UVB, with UVC filtered out. The mice's eyes were covered so the effect would come through the skin rather than the retina.1
Irradiation ran three times a week for twelve weeks. The dose started at 100 mJ/cm², which the authors define as one minimal erythema or edema dose, and was raised every two weeks until it reached 400 mJ/cm², four times that threshold, where it stayed. Total accumulated dose was 10,800 mJ/cm². The paper states that the skin "typically displayed mild erythema after each UV irradiation session" and that if a mouse showed only mild redness or none, the dose was raised further.1
Food intake and body weight were measured weekly. Energy use was measured in metabolic cages at baseline, 6 weeks and 12 weeks. Tissue from skin, inguinal (groin) subcutaneous fat, blood and the hypothalamus was collected at the end, 24 hours after the last UV session and after a 6-hour fast.1 The authors ran the main experiment twice in parallel. In the first run each group was 2 cages of 5 mice, and in the second each group was 4 cages of 2 mice, with food intake and weight recorded per cage.1
A third experiment tested whether norepinephrine was the cause. High-fat-fed mice got UV for 10 weeks, and from week 7 half received nepicastat, a drug that blocks the enzyme that converts dopamine into norepinephrine, by injection into the abdomen at 30 mg/kg. The carrier was saline with 1.5% dimethylsulfoxide and 1.5% Cremophor EL, and the comparison group received the same carrier without the drug. Each group in this run was 3 cages of 2 mice.1
Funding came from Seoul National University's New Faculty Startup Fund, the Korean Ministry of Health and Welfare, and the National Research Foundation of Korea. The authors declare no conflict of interest.1
What they found, week by week
Evidence: the paper's own results, reported as the authors present them.
The sequence matters more than the summary, so here it is in order.
Week 2
Serum norepinephrine was already significantly higher in UV-treated mice, before any other measure had moved.1
Week 7
Food intake began to climb in the UV groups. The authors note that this is roughly when serum leptin had become "considerably reduced."1
Week 8
Leptin, the fat-derived hormone that signals fullness to the brain, was significantly lower in the blood of UV mice on both diets.1 Ghrelin, the stomach's hunger hormone, showed no consistent change. Insulin was lower at 12 weeks.
Week 12
UV mice on the normal diet had eaten more than sham mice but weighed about the same. UV mice on the high-fat diet had eaten more and weighed less than their sham counterparts, and the authors describe the weight difference as "more marked" in the high-fat group.1 In the hypothalamus, the appetite-driving signals neuropeptide Y and AgRP were up and the appetite-suppressing POMC protein was down. Leptin mRNA was lower in skin and inguinal fat.
The inguinal fat pads of UV mice were smaller and had taken on a reddish color. Under the microscope the fat cells were smaller, with the many small lipid droplets typical of beige fat, and they expressed more UCP1 and more β3-adrenergic receptor. Metabolic cages showed UV mice consuming more oxygen and producing more heat in both the light and dark phases, with no change in how much they moved.1
A screen of 28 neurotransmitters in the skin found norepinephrine 1.4 times higher in normal-diet UV mice and about 2 times higher in high-fat UV mice compared with their sham groups. Several others rose too: GABA, glutamate, aspartate, serotonin and dopamine all went up in UV skin.1 The paper follows norepinephrine and does not discuss the others.
The nepicastat run
By week 10, mice on UV plus nepicastat had regained weight relative to UV mice on carrier alone, a difference the authors report as significant. Their food intake also came back down, but the authors write that this did not reach significance "because of the statistical sample size of only 3." Nepicastat lowered norepinephrine in blood, skin and fat, raised leptin back up, restored fat cell size, and reversed the UCP1 increase.1
Norepinephrine is the body's stress signal
Evidence: mechanism, attributed to the paper and the same lab's earlier work.
The paper introduces norepinephrine as the main neurotransmitter of the sympathetic nervous system, one that "functions as a fight-or-flight stress hormone that responds to environmental stressors or dangers."1 It is released into fat tissue under sympathetic activation such as a cold challenge, where it drives lipolysis and heat production and suppresses leptin synthesis.1 Browning of white fat is a sympathetic response. So is the heat the metabolic cages picked up.
The same Seoul National University group published a related study in 2017. After two weeks of UV to the skin of male mice, they recorded activation of the hypothalamic-pituitary-adrenal axis, higher serum corticosterone, fewer immature neurons in the hippocampus, and lower levels of the growth factor BDNF. After six weeks the mice showed depression-like behavior on a standard test.3 That paper reads the skin's response to repeated UV as a stress response. The 2024 paper, from the same lab, reads the downstream weight effect as a possible therapy. Both can be true of the same pathway. The question for a reader is which description fits a person better.
The authors' own data gives the order of events. Norepinephrine rose at week 2, before any change in appetite, leptin, or weight. The fat changes followed. In a mouse, the first measurable response to this schedule of UV was a sustained rise in a stress hormone. Whether twelve weeks of that is a benefit or an adaptation with a weight side effect is a judgment the paper does not make.
What "UV exposure" meant in this study
Evidence: the paper's methods, compared with the dosing in two other mouse studies.
The mice were, in plain terms, mildly sunburned three times a week for three months. The dose was defined by the reddening threshold, raised to four times that threshold, and adjusted upward whenever the skin stopped reacting.1 The lamps were UVB, the burning band, not the broad spectrum a person receives outdoors. The skin was shaved. A person would need to spend most of a day in strong sun with no protection, every other day, and keep it up through a season, to come close.
Dose is where the UV and metabolism literature splits. A 2020 study from the Telethon Kids Institute in Western Australia gave male mice on a high-fat diet a low, non-burning dose of UVB, 1 kJ/m² twice a week, for 12 weeks. UV on its own had no significant effect on food intake, body fat, or blood sugar.5 A 2022 paper in Nature Metabolism from Tel Aviv University found the opposite appetite effect from the Seoul study: UVB increased food-seeking, food intake and weight gain in male mice through the hunger hormone ghrelin, and reported more food intake in men than women after sun exposure in a survey of about 3,000 people. In females, estrogen blocked the ghrelin response.4 The Seoul authors acknowledge this and write that the effects of UV on metabolism "vary considerably" by wavelength, dose, animal model, and sex.1
Three labs used different doses and reached different answers, and the 2024 result sits at the high-dose end of that range.
Why these mice don't translate to people
Evidence: limitations stated by the authors, plus standard concerns with rodent metabolic studies.
Female only, estrogen unexamined
The authors used female mice because shaved, UV-exposed males became aggressive, fought, and developed skin wounds that would have confounded the inflammation readings. They state that the study "did not rule out the effect of UV irradiation on estrogen levels" and that this needs further work.1 Given that the Tel Aviv group found estrogen controls the appetite response to UV in females,4 this is a large open question sitting underneath the whole result.
Small groups, measured by the cage
Food intake and body weight were recorded per cage. Run one had 2 cages per group and run two had 4. The nepicastat run had 3, which the authors themselves name as the reason one of its results missed significance.1 Tissue measurements used 7 to 10 mice per group, which is more typical, but the headline finding about appetite rests on very few data points.
Tissue collected once, blood not flushed
Skin and fat were sampled only at the 12-week endpoint, so the authors note that "dynamic changes in other tissues might have been missed." They also did not perfuse the tissues before collection and write that they "cannot entirely rule out the influence of residual blood" on the norepinephrine readings in skin and fat.1
The room was cold for a mouse
The mice were housed at 72°F (22°C), give or take 4°F (2°C).1 That is standard laboratory practice, and it is well below a mouse's thermoneutral zone. Calorimetry work from Stockholm University reports that mice under standard housing conditions of about 68°F (20°C) are under constant cold stress, running at roughly 3.1 times basal metabolic rate, compared with 1.8 times at thermoneutrality, which is the ratio humans live at.6 Cold is the classic trigger for sympathetic activation and fat browning. These mice were already leaning on that pathway before the lamps came on.
Laboratory mice are not wild mice
Lab rodent strains have been bred in captivity for many generations. Work by Bret Weinstein and Deborah Ciszek documented that the breeding practices used in colonies have shifted the baseline genetics of laboratory mice, including telomere length, away from wild populations, which complicates using them to test how a treatment affects long-term health in a normal animal.7 C57BL/6 is one such inbred strain.
The one human finding
Evidence: cell culture, reported in the supplementary material.
The paper's human data is a dish. Fat cells grown from subcutaneous tissue removed during liposuction, along with skin keratinocytes and fibroblasts from foreskin, were irradiated directly with 100 mJ/cm² UV. Twenty-four hours later the fat cells had made more norepinephrine and more of the enzyme that produces it. The skin cells had not.1 The authors take this as support for fat cells in the skin being a source of UV-induced norepinephrine.
In a living person, UV does not reach subcutaneous fat. The authors say so in their own introduction, where they describe UV's effect on fat as indirect, carried by cytokines made in the epidermis and dermis.1 Cells in a dish also have no nervous system, no hormones arriving from elsewhere, and no twelve weeks of anything. This result shows a cell can respond to UV. It does not show that a person's fat does so from a day in the sun.
What the authors want to do with this
Evidence: the paper's conclusion and the authors' quoted statements.
Three statements from the same team sit side by side. The paper's final sentence proposes that "UVR can be used as a potential therapeutic intervention for obesity-associated metabolic disorders."1 In the press release, co-corresponding author Dong Hun Lee says that because UV accelerates skin aging and promotes skin cancer, "it is advisable to minimize UV exposure and protect the skin with sunscreen."2 And the release closes with the team's plan to "develop new strategies that could mimic the effects of UV radiation."2
Read together, the research points toward a product that reproduces one of the sun's effects on a stress pathway, with the sun itself left out. My position on anything that comes out of that pipeline is the same as for every new metabolic intervention without long-term safety data: remain in the control group.
The sun-safety debate has two sides
Evidence: observational cohorts and registry data on both sides; no randomized trial settles it.
The advice attached to this study, minimize UV and wear sunscreen, is the position of the American Academy of Dermatology, the Skin Cancer Foundation, and the FDA, which regulates sunscreen as an over-the-counter drug and recommends broad-spectrum products of SPF 15 or higher alongside limiting time in the sun. Skin cancers are the most common cancers in the United States, and that fact is the basis for the advice.8 A reader deserves the other side too, because the research record on sunlight and death is not one-sided.
The case that sun avoidance carries its own cost
A physician writing anonymously as A Midwestern Doctor laid out this case in a June 2026 essay, "Dermatology's Crusade Against the Sun," and the primary studies behind it can be checked directly.8 The central one is the Melanoma in Southern Sweden cohort: 29,518 women aged 25 to 64 at enrollment, followed for 20 years. Women who avoided the sun died at higher rates than women with active sun habits, mainly from cardiovascular disease and from causes other than cancer. Nonsmokers who avoided the sun had a life expectancy similar to smokers in the highest sun exposure group, and the authors describe sun avoidance as a risk factor for death "of a similar magnitude as smoking," with avoiders losing 0.6 to 2.1 years of life expectancy compared with the highest-exposure group.9 A 2009 review by Cedric Garland's group at UC San Diego gathered the observational data linking higher vitamin D levels to substantially lower rates of colon, breast, ovarian, aggressive prostate and other cancers, and sunlight on skin is the main natural source of vitamin D.14
Melanoma and sunlight
The deadliest skin cancer is melanoma, and its relationship to sun is less settled than public messaging suggests. A 2005 study in the Journal of the National Cancer Institute followed 528 melanoma patients for more than five years. A history of sunburn, high intermittent sun exposure, and solar elastosis (the microscopic signature of long-term sun damage in the skin) were each associated with a lower risk of dying from the melanoma. Patients whose skin showed solar elastosis were about 60% less likely to die of their melanoma than those without it, after adjusting for tumor thickness and other factors. The authors' one-line conclusion: "Sun exposure is associated with increased survival from melanoma."10
A 1998 comparative analysis in Mutation Research compared the three main skin cancers by age pattern, sex ratio, body distribution, and latitude, and concluded that squamous cell carcinoma is almost entirely sun-caused, basal cell partly so, and melanoma not, noting that melanoma favors body sites that see little sun.11 And a 2009 analysis of every melanoma reported in East Anglia from 1991 to 2004 found that incidence rose from 9.39 to 13.91 cases per 100,000 almost entirely through stage 1 lesions, with no change in the other stages and mortality moving only from 2.16 to 2.54 per 100,000. The authors attributed the "epidemic" to diagnostic drift, benign lesions being reclassified as early melanoma, and noted that the lesion sites did not match where sun falls.12 The Midwestern Doctor essay draws these threads together into the argument that the deadliest skin cancers are linked to a lack of sunlight rather than to an excess of it.8
Sunscreen and skin cancer rates
A 2023 UK Biobank analysis from McGill University, covering 472,672 people, was built to find DNA-repair gene variants that predict skin cancer. Its sun-protection variable was one self-report question with five answers, from "never/rarely" through "sometimes," "most of the time," and "always" to "do not go out in sunshine," and the authors use "sunscreen" and "sun protection" interchangeably when describing it. Compared with people who never or rarely used protection, those who always used it had 2.40 times the rate of basal cell carcinoma and 2.26 times the rate of squamous cell carcinoma. For melanoma in situ, the "sometimes" through "always" groups carried 1.87 to 3.58 times the rate, and for invasive melanoma 1.36 to 3.92 times.13 The authors' own figure caption states that frequent use of sun protection and limited outdoor exposure "show moderately-to-strongly increased risk of all skin cancers."13 They call the result a paradox and offer three explanations: more UV exposure among users, failure to reapply through the day, and people starting protection after a diagnosis, while noting that their self-reported data cannot separate behavior before diagnosis from behavior after it.13 Senior author Ivan Litvinov has said people use sunscreen "as a permission slip to tan."15 The Midwestern Doctor reads the same tables and asks why the model is not questioned instead of the users.8 Both readings are available to you.
Who benefits from the message
The essay also traces the history of the campaign: the American Academy of Dermatology's 1985 national skin cancer screening program, an account from dermatologist David Elpern that the Academy spent more than two million dollars in the early 1980s on a New York advertising agency to rebrand dermatologists as skin cancer specialists, and a 700% rise in Mohs surgery among Medicare patients between 1992 and 2009.8 These are the essay's claims, drawn from secondary sources it cites, and I have not verified each one independently. They are included so you know the financial side of the debate exists.
Where I land, as the author of this site, is that both sides are citing observational data, and the sun is not a drug with a label. Regular, moderate, seasonal exposure that never burns is the practice humans lived with before any of these studies, and nothing above argues against it. What this UV mouse paper shows is what happens at the far end of the dose range, and neither side of the sun debate is asking you to go there.
Cautions on record for UV exposure
Evidence: dermatology and pharmacology references.
Dermatology texts record photoaging, sunburn, and an increased risk of skin cancers, including melanoma, with cumulative and intermittent high-dose UV exposure, and the authors of this study repeat those cautions.1,2 The FDA's position, stated on every sunscreen label it regulates, is that limiting time in the sun, wearing protective clothing, and using a broad-spectrum sunscreen of SPF 15 or higher reduces the risk of skin cancer and early skin aging. The section above sets out the evidence that cuts the other way. Pharmacology references list many medications and some herbs that increase sensitivity to UV, among them certain antibiotics, diuretics, retinoids, and St. John's wort, with reactions ranging from faster burning to blistering. Anyone taking a prescription or using herbs regularly can ask a pharmacist or clinical herbalist to check their own list for photosensitizers before increasing time in the sun.
Reading this as a sunlight question
Evidence: traditional practice and observational; no claims about weight.
Set the weight headline aside and what remains is a reminder that skin is a sensing organ. Light on skin changes what the body makes, and the body responds. That is as true of the gentle version, morning light on your face and arms, as of the lamp schedule in this paper, but the two are not the same exposure and this study says nothing about the first.
What traditional practice has always recommended is regular, moderate daylight that follows the season: more in summer, less in winter, enough to warm the skin and never enough to burn it. A short morning walk gives you the light signal and the movement together. For skin that will be in strong sun longer than it is used to, a mineral balm is my preference over chemical filters; I covered how I make mine and which brands pass my ingredient check in the mineral sunscreen article.
If weight is the concern that brought you to this study, the hormone most worth checking is not norepinephrine. I wrote about the thyroid side of stalled weight loss in weight loss struggles and hypothyroidism, and about the difference between the body's stress response and a nourished one in the adaptogen guide. A pathway that works by keeping a stress hormone elevated for weeks is the opposite of what I want for a client's metabolism, whatever it does to the scale.
Frequently asked questions
Does sunlight make you lose weight?
This study did not test that. It found that female mice under a burning-level UVB schedule for 12 weeks gained less weight than sham-treated mice despite eating more. No human weight data was collected.1
Was this tested in people?
Only in cultured human fat cells and skin cells in a dish. No people were exposed to UV in this study.1
Why did the mice eat more?
The authors attribute it to lower leptin. Norepinephrine suppresses leptin production in fat, and with less leptin reaching the brain, the hypothalamus turned up its appetite signals.1
Is norepinephrine the same as adrenaline?
No, but they are close relatives. Norepinephrine (noradrenaline) is the main neurotransmitter of the sympathetic nervous system and is also made in the adrenal glands. Adrenaline (epinephrine) is made from norepinephrine. The paper describes norepinephrine as a fight-or-flight stress hormone.1
Does sunscreen cancel the effect?
The study did not test sunscreen. The lamps used were UVB, which is the band mineral and chemical sunscreens are designed to block, so a sunscreen that works would be expected to reduce the dose reaching the skin. The authors themselves recommend sunscreen.2 Whether habitual sunscreen use lowers skin cancer rates in practice is contested; see the sun-safety section above.13
Is sun exposure linked to melanoma deaths?
The record is mixed. A 2005 JNCI study found melanoma patients with more sun damage in their skin were about 60% less likely to die of the disease, and a 20-year Swedish cohort found women who avoided the sun died earlier overall. Dermatology bodies maintain that UV exposure raises skin cancer risk. Both positions rest on observational data.8,9,10
Why were only female mice used?
The authors report that shaved, UV-exposed male mice became aggressive and wounded each other, which would have confounded the results. They note that estrogen's role was not examined.1
Sources
- Quan QL, Kim EJ, Kim S, et al. UV Irradiation Increases Appetite and Prevents Body Weight Gain through the Upregulation of Norepinephrine in Mice. J Invest Dermatol. 2024;144(10):2273-2284.e5. PMID 38775766. doi:10.1016/j.jid.2024.03.012. Funded by Seoul National University, the Korean Ministry of Health and Welfare, and the National Research Foundation of Korea. Authors declare no conflict of interest.
- Elsevier. Dermatologists Find Ultraviolet Irradiation Increases Appetite but Prevents Body Weight Gain. Press release, May 22, 2024. Issued by the journal's publisher to promote the paper. elsevier.com.
- Han M, Ban JJ, Bae JS, Shin CY, Lee DH, Chung JH. UV irradiation to mouse skin decreases hippocampal neurogenesis and synaptic protein expression via HPA axis activation. Sci Rep. 2017;7:15574. PMID 29138442. doi:10.1038/s41598-017-15773-z. Same laboratory as source 1.
- Parikh S, Parikh R, Michael K, et al. Food-seeking behavior is triggered by skin ultraviolet exposure in males. Nat Metab. 2022;4(7):883-900. PMID 35817855. doi:10.1038/s42255-022-00587-9.
- Allemann TS, Dhamrait GK, Fleury NJ, et al. Low-dose UV radiation before running wheel access activates brown adipose tissue. J Endocrinol. 2020;244(3):473-486. PMID 31905167. doi:10.1530/JOE-19-0470.
- Fischer AW, Cannon B, Nedergaard J. Optimal housing temperatures for mice to mimic the thermal environment of humans: An experimental study. Mol Metab. 2018;7:161-170. PMID 29122558. doi:10.1016/j.molmet.2017.10.009.
- Weinstein BS, Ciszek D. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp Gerontol. 2002;37(5):615-627. doi:10.1016/s0531-5565(02)00012-8.
- A Midwestern Doctor. Dermatology's Crusade Against the Sun. The Forgotten Side of Medicine (Substack), June 25, 2026. midwesterndoctor.com. Written by an anonymous practicing physician; reader-supported newsletter with no disclosed industry funding. Secondary source; the studies it cites are listed below as 9 through 14.
- Lindqvist PG, Epstein E, Nielsen K, Landin-Olsson M, Ingvar C, Olsson H. Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohort. J Intern Med. 2016;280(4):375-387. PMID 26992108. doi:10.1111/joim.12496.
- Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97(3):195-199. PMID 15687362. doi:10.1093/jnci/dji019. US Public Health Service funded.
- Christophers AJ. Melanoma is not caused by sunlight. Mutat Res. 1998;422(1):113-117. PMID 9920435. doi:10.1016/s0027-5107(98)00182-1.
- Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night's dream? Br J Dermatol. 2009;161(3):630-634. PMID 19519827. doi:10.1111/j.1365-2133.2009.09299.x.
- Jeremian R, Xie P, Fotovati M, Lefrançois P, Litvinov IV. Gene-Environment Analyses in a UK Biobank Skin Cancer Cohort Identifies Important SNPs in DNA Repair Genes That May Help Prognosticate Disease Risk. Cancer Epidemiol Biomarkers Prev. 2023;32(11):1599-1607. PMID 37642678. doi:10.1158/1055-9965.EPI-23-0545.
- Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19(7):468-483. PMID 19523595. doi:10.1016/j.annepidem.2009.03.021. Review article.
- McGill University Newsroom. Sunscreen is important, says Dr. Ivan Litvinov, but it is also the least effective way to protect your skin. October 24, 2023. mcgill.ca. University press office statement by the senior author of source 13.